LAZZARI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 3.918
NA - Nord America 2.431
AS - Asia 2.110
SA - Sud America 173
AF - Africa 105
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.748
Nazione #
US - Stati Uniti d'America 2.323
DE - Germania 1.582
GB - Regno Unito 1.204
CN - Cina 782
SG - Singapore 643
IT - Italia 334
SE - Svezia 173
HK - Hong Kong 170
RU - Federazione Russa 142
BR - Brasile 139
FR - Francia 109
IN - India 92
NL - Olanda 90
VN - Vietnam 89
CA - Canada 84
BD - Bangladesh 79
EG - Egitto 64
IE - Irlanda 62
FI - Finlandia 51
JP - Giappone 46
DK - Danimarca 45
ID - Indonesia 39
TR - Turchia 36
KR - Corea 33
UA - Ucraina 33
CI - Costa d'Avorio 20
BE - Belgio 17
AR - Argentina 13
ES - Italia 13
MX - Messico 12
MY - Malesia 12
GR - Grecia 11
TW - Taiwan 11
SA - Arabia Saudita 9
AT - Austria 8
AU - Australia 8
EC - Ecuador 8
PH - Filippine 8
PL - Polonia 8
IQ - Iraq 7
ZA - Sudafrica 7
IL - Israele 6
IR - Iran 6
LU - Lussemburgo 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 4
KW - Kuwait 4
MA - Marocco 4
NO - Norvegia 4
NP - Nepal 4
PK - Pakistan 4
RO - Romania 4
AL - Albania 3
BH - Bahrain 3
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
TH - Thailandia 3
VE - Venezuela 3
BG - Bulgaria 2
EU - Europa 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
PT - Portogallo 2
PY - Paraguay 2
SC - Seychelles 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GA - Gabon 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
UY - Uruguay 1
Totale 8.749
Città #
Frankfurt am Main 1.145
Southend 1.143
Singapore 402
Ashburn 330
Hanover 277
Chandler 170
Beijing 151
Hong Kong 151
Milan 141
San Jose 109
Wilmington 103
Council Bluffs 90
Dearborn 90
Ann Arbor 88
Seattle 80
Dallas 75
Princeton 73
New York 62
Fairfield 61
Dublin 59
Los Angeles 48
Houston 44
Grafing 40
Helsinki 38
Nanjing 38
Toronto 37
Woodbridge 37
Guangzhou 35
Santa Clara 34
Lauterbourg 33
Bengaluru 32
Ho Chi Minh City 29
Jakarta 29
Tokyo 29
Des Moines 28
Hanoi 28
Munich 26
Cambridge 25
Phoenix 25
Changsha 24
Shanghai 24
Jinan 23
Istanbul 22
Cairo 21
Abidjan 20
Boardman 20
Buffalo 19
Columbus 19
Mountain View 19
The Dalles 19
Hangzhou 18
Zhengzhou 18
Brussels 17
Nanchang 17
Tianjin 17
San Diego 16
Brooklyn 15
Cangzhou 15
Redwood City 15
Rome 15
Hebei 14
Moscow 14
Medford 13
Ottawa 13
Sohag 13
Basingstoke 12
Seoul 12
Shenyang 12
Boston 11
Chicago 11
Falls Church 10
Ningbo 10
La Jolla 9
Shenzhen 9
Central 8
Fremont 8
Fuzhou 8
Ipoh 8
Wuhan 8
Areannamkwaengi 7
Berlin 7
Cheney 7
Lucknow 7
Redmond 7
São Paulo 7
Athens 6
Atlanta 6
Jiaxing 6
London 6
Lubbock 6
Luxembourg 6
Newark 6
Yubileyny 6
Aga 5
Amsterdam 5
Andover 5
Chengdu 5
Denver 5
Gothenburg 5
Haiphong 5
Totale 6.156
Nome #
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance 677
MECHANISMS OF DRUG-ESCAPE AND RELAPSE IN MULTIPLE MYELOMA: INTERPLAY BETWEEN ADAR1 AND NOTCH IN ABERRANT RNA EDITING 420
Notch signaling promotes drug resistance in multiple myeloma through the regulation of the CXCR4/SDF1α axis 378
Notch signaling drives multiple myeloma induced osteoclastogenesis 330
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche 327
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 319
Jagged1/2 inhibition promotes multiple myeloma cell sensitivity to Bortezomib in vitro, ex-vivo and in vivo in a novel zebrafish model 315
AKT promotes the oncogenic Notch signaling in T-cell acute lymphoblastic leukemia 296
Notch signaling promotes bone marrow-induced drug resistance in multiple myeloma through the regulation of the CXCR4/CXCL12 system 292
AKT regulation of oncogenic Notch pathway in T-cell acute lymphoblastic leukemia 282
The role of notch pathway in multiple myeloma progression toward IL-6 independence 268
Multiple myeloma-associated drug resistance : targeting the Notch pathway 266
Notch targeting prevents multiple myeloma associated osteoclastogenesis 266
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma 262
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma 260
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma 252
The Notch pathway controls multiple myeloma crosstalk with the osteoclastogenic niche 251
Jagged-induced notch signaling promotes endogenous and bone marrow-mediated drug resistance in multiple myeloma 251
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance 230
PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation 227
Understanding the interaction of human cancer cells with the surrounding microenvironment: the new challenge in modern oncology 216
Notch receptors regulate multiple myeloma-driven osteoclastogenesis 208
Jagged-directed therapy in multiple myeloma: a new approach to interrupt the crosstalk between the tumor cell and the bone marrow microenvironment 202
Notch signaling dysregulation promotes multiple myeloma-associated bone disease 201
Relationship of the oncogene Notch and CXCR4/SDF1 signaling in human epithelial ovarian cancer 198
Promotion of human multiple myeloma cell growth in vitro and bone marrow invasion in vivo by Notch receptors and the CXCR4/SDF1 axis 197
Chemokine receptors as novel targets of the oncogene Notch1 in acute lymphoblastic leukemia 195
The Notch pathway controls multiple myeloma induced osteoclastogenesis 192
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance 190
ADAR1-dependent RNA editing is a mechanism of therapeutic resistance in human plasma cell malignancies 188
The role of notch pathway in multiple myeloma associated drug resistance 184
The Notch pathway drives the ability of the bone marrow niche to promote RNA editing in multiple myeloma 182
Notch signaling drives myeloma cells homing to the bone marrow by regulating the CXCR4/CXCL12 axis 157
The role of Notch in the regulation of osteoclastogenesis in multiple myeloma 148
Generation of a stable fluorescent cell cycle reporter myeloma cell line for real-time evaluation of microenvironment-responsive and drug-induced cell cycle alterations 145
Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor 112
Totale 9.084
Categoria #
all - tutte 21.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 70 37
2021/2022904 71 42 61 67 64 87 69 65 96 79 94 109
2022/2023663 67 67 78 58 72 124 10 53 70 15 34 15
2023/20241.130 12 28 31 39 128 20 173 148 77 137 164 173
2024/20251.601 161 199 130 208 91 62 34 120 76 153 113 254
2025/20262.008 246 137 162 175 220 179 250 74 174 147 244 0
Totale 9.084